Savvidou Α. et al. 2026. Real-World Data on the Use of Cyclin-Dependent Kinase 4/6 Inhibitors in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced/Metastatic Breast Cancer. World Journal of Oncology. 17, 3 (Jan. 2026), 380–393. DOI:https://doi.org/10.14740/wjon2750.